Drug-Free Emotional Regulation Pilot Launches in California as U.S. Mental Health System Faces Mounting Strain At a time when the U.S. mental health system is grappling with persistent funding instability,…
Innovaccer Showcases Expanding AI Ecosystem as Healthcare Leaders Confront Workforce, Financial, and Administrative Pressures at Xccelerate 2026 Innovaccer, a healthcare AI company focused on data unification and intelligent automation, concluded…
Life Sciences Ontario Announces 2026 Awards Celebrating Excellence, Leadership, and Innovation Across the Life Sciences Sector Life Sciences Ontario (LSO) has announced the recipients of the 2026 LSO Awards, recognizing…
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Fund to Accelerate Life Sciences Innovation The University of Pennsylvania BioNTech SE and Osage University Partners (“OUP”) have announced the launch…
Medcare Expands Access to Breakthrough Intrathecal Gene Therapy for Spinal Muscular Atrophy, Treats First International Older Patient Medcare Women & Children Hospital has reached a significant milestone in the treatment…
Netsmart Reinforces Interoperability Leadership by Joining CMS Health Technology Ecosystem Pledge Netsmart, a leading provider of healthcare technology solutions and services for community-based care organizations, today announced its formal commitment…
Luskin Orthopaedic Institute Delivers Holiday Cheer to 1,000 Kids Luskin Orthopaedic Institute for Children (LuskinOIC) once again transformed its Downtown Los Angeles campus into a place of wonder, joy, and…
GenSci, RTW Investments, and Yarrow Bioscience Enter Strategic Global Partnership to Advance First-in-Class Anti-TSHR Antibody for Graves’ Disease and Thyroid Eye Disease SHANGHAI & NEW YORK Shanghai Scizeng Medical Technology…
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral suspension, a first-in-class, single-dose oral antibiotic for…
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America, Expanding Access to Pathogen Reduction Technologies CONCORD Calif Cerus Corporation announced that it has finalized a new group purchasing…
Stoke and Biogen Share New Zorevunersen Data in Dravet Syndrome Stoke Therapeutics and Biogen have announced new long-term clinical data that continue to strengthen the evidence supporting zorevunersen as a…
Mango Sciences Partners With ImmunoACT to Expand Access and Affordability of CAR-T Therapy for Cancer Patients in India Through Innovative Financing and Value-Based Care Mango Sciences, Inc., a data and…